×
News Home

Should You Buy salesforce.com, inc. (CRM) Stock Tuesday?

Tuesday, January 25, 2022 02:21 PM | InvestorsObserver Analysts
Should You Buy salesforce.com, inc. (CRM) Stock Tuesday?

InvestorsObserver gives salesforce.com, inc. (CRM) a weak valuation score of 8 from its analysis. The proprietary scoring system considers the underlying health of a company by analyzing its stock price, earnings, and growth rate. CRM currently holds a better value than 8% of stocks based on these metrics. Long term investors focused on buying-and-holding should find the valuation ranking system most relevant when making investment decisions.

Valuation Rank - 8
CRM gets a 8 Valuation Rank today. Find out what this means to you and get the rest of the rankings on CRM!

Metrics Analysis

CRM has a trailing twelve month Price to Earnings (PE) ratio of 123.9. The historical average of roughly 15 shows a poor value for CRM stock as investors are paying higher share prices relative to the company's earnings. CRM's high trailing PE ratio shows that the firm has been trading above its fair market value recently. Its trailing 12-month earnings per share (EPS) of 1.80 does not justify the stock's current price. However, trailing PE ratios do not factor in the company's projected growth rate, resulting in many newer firms having high PE ratios due to high growth potential enticing investors despite inadequate earnings. CRM's 12-month-forward PE to Growth (PEG) ratio of 5.51 is considered a poor value as the market is overvaluing CRM in relation to the company's projected earnings growth due. CRM's PEG comes from its forward price to earnings ratio being divided by its growth rate. A PEG ratio of 1 represents a perfect correlation between earnings growth and share price. Due to their incorporation of more fundamentals of a company's overall health and focusing on the future rather than the past, PEG ratios are one of the most used valuation metrics by analysts today.

Summary

CRM's valuation metrics are weak at its current price due to a overvalued PEG ratio despite strong growth. CRM's PE and PEG are worse than the market average resulting in a below average valuation score. Click Here to get the full Report on salesforce.com, inc. (CRM) stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App